BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 1704634)

  • 21. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
    Rosser CJ; Parker A
    J Urol; 2005 Sep; 174(3):1154-5; author reply 1155-6. PubMed ID: 16094093
    [No Abstract]   [Full Text] [Related]  

  • 22. Prostate cancer-associated markers.
    Chu TM
    Immunol Ser; 1990; 53():339-56. PubMed ID: 1713065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of prostatic acid phosphatase and prostate specific antigen as serum markers in carcinoma of the prostate.
    Akdaş A; Simşek F; Ilker Y; Türkeri L; Ercan H
    Int Urol Nephrol; 1993; 25(3):271-8. PubMed ID: 7693607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Re: Gamma-seminoprotein--a new tumour marker in prostatic cancer?
    Scheit KH
    Br J Urol; 1991 Sep; 68(3):331-2. PubMed ID: 1717099
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparison of 3 assay kits of prostate specific antigen in serum of prostatic cancer].
    Akimoto S; Akakura K; Shimazaki J
    Hinyokika Kiyo; 1988 Dec; 34(12):2143-8. PubMed ID: 2467543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostatic specific antigen in prostate cancer.
    Wozniak-Petrofsky J
    Urol Nurs; 1992 Sep; 12(3):104-5. PubMed ID: 1382317
    [No Abstract]   [Full Text] [Related]  

  • 27. [New prospective diagnostic serum markers in prostatic cancer].
    Mirone V; De Bellis G; Prezioso D; Sanseverino R; Iannucci F; Padulano P
    Minerva Med; 1986 Mar; 77(13):503-4. PubMed ID: 2422605
    [No Abstract]   [Full Text] [Related]  

  • 28. [Isoenzymes of creatine kinase and prostate-specific antigen in the monitoring of prostatic carcinoma].
    Scarazatti E; Lino S; Martinoli F; Borroni A
    Boll Soc Ital Biol Sper; 1990 Jun; 66(6):581-5. PubMed ID: 1701647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Early detection of prostatic cancer].
    Weissbach L
    Urologe A; 1992 Jul; 31(4):193-4. PubMed ID: 1381124
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effects of transurethral resection on the serum concentration of prostate specific antigen and prostatic acid phosphatase].
    Morote J; de Torres JA
    Actas Urol Esp; 1990; 14(5):356-7. PubMed ID: 1705076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical evaluation of serum prostatic specific antigen in prostatic cancer: simultaneous assays of prostatic specific antigen, gamma-seminoprotein and prostatic acid phosphatase in 113 newly diagnosed patients with prostatic cancer].
    Arai Y; Yoshki T; Okada K; Yoshida O; Yamamoto N; Sakatoku J; Sugimura Y; Kawamura J
    Hinyokika Kiyo; 1989 Sep; 35(9):1519-28. PubMed ID: 2479237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for adenocarcinoma of the prostate.
    Miles BJ
    Henry Ford Hosp Med J; 1989; 37(1):5-7. PubMed ID: 2475458
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical evaluation of gamma-seminoprotein as a serum marker of prostate carcinoma].
    Sugimura Y; Sakurai M; Hioki T; Hayashi N; Yamakawa K; Tajima K; Tochigi H; Kawamura J
    Hinyokika Kiyo; 1988 Dec; 34(12):2129-34. PubMed ID: 2467541
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory assessment of prostate status.
    Saito Y
    Clin Lab Med; 1993 Mar; 13(1):279-86. PubMed ID: 7681740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
    Tarle M
    Anticancer Res; 1993; 13(3):769-77. PubMed ID: 7686362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The clinical use of the prostate-specific antigen in patients with prostatic cancer].
    Matveev BP; Sokolov AV; Bukharkin BV; Ledian KM; Tilk AE; Makarova GV
    Urol Nefrol (Mosk); 1991; (4):8-12. PubMed ID: 1719686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [PSA in the staging and monitoring of cancer of the prostate].
    Gil Sanz MJ; Sanz Velez JI; Liedana Torres JM; Roncales Badal AL; Allepuz Losa C; Rioja Sanz LA
    Actas Urol Esp; 1991; 15(6):527-31. PubMed ID: 1724347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate-specific antigen: a valuable clinical tool.
    Oesterling JE
    Oncology (Williston Park); 1991 Apr; 5(4):107-22; discussion 122, 125-6, 128. PubMed ID: 1714288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prostate-specific antigen as a prostatic tumor marker. Analysis of results in 206 patients].
    Rodríguez Duarte C
    Arch Esp Urol; 1991; 44(6):697-700. PubMed ID: 1722962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of prostate-specific antigen as a screening test for prostate cancer.
    N Engl J Med; 1991 Sep; 325(13):963-5. PubMed ID: 1715514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.